ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease
Crossref DOI link: https://doi.org/10.1245/s10434-018-7046-9
Published Online: 2018-11-21
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murphy, Brittany L.
Boughey, Judy C.
Text and Data Mining valid from 2018-11-21
Article History
Received: 1 November 2018
First Online: 21 November 2018
Disclosures
: The authors have no conflicts of interest to disclose.